Skip to main content

Advertisement

Log in

Nuclear expression of CXCR4 is associated with advanced colorectal cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and objectives

CXCR4 and its ligand, SDF-1α, play an important role in the targeted metastasis of colon cancer. In this study, we analyzed an expression of CXCR4 in clinical samples and showed that SDF-1α affected the expression of CXCR4 in colon cancer cells.

Materials and methods

A total of 388 patients with colorectal cancer (CRC) who underwent surgery in Taipei Veterans General Hospital from 2000 to 2004 were included. The expression of CXCR4 in CRC was visualized by immunohistochemistry (anti-CXCR4 mAb, R&D 12G5). HCT116, SW480, and SW620 cells were treated with SDF-1α in vitro and the CXCR4 proteins located in the cytoplasmic and nuclear compartments were separated and analyzed with western blotting.

Results

The frequency of cytoplasmic and nuclear expression of CXCR4 in colorectal cancers was 35.6% and 36.9%, respectively. Nuclear but not cytoplasmic expression of CXCR4 was associated with advanced CRC (p < 0.001) and lymphovascular invasion. However, in multivariate analysis, nuclear expression of CXCR4 did not correlate with patients' outcome. In the in vitro study, SDF-1α, stimulation of three colorectal carcinoma lines enhanced the CXCR4 nuclear expression.

Conclusion

Expression of the CXCR4 plays a role in CRC progression and may be associated with SDF-1α stimulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CRC:

Colorectal cancer

DFS:

Disease-free survival

References

  1. The Department of Health, Executive Yuan (2007) Cancer registry annual report. R.O.C., Taiwan

    Google Scholar 

  2. Stetler-Stevenson WG, Kleiner DeVita VT, Hellman S, Rosenberg SA (2001) Molecular biology of cancer: invasion and metastasis. Principles and Practice of Oncology. Lippincott Williams & Wilkins, Philadelphia, pp 123–136

    Google Scholar 

  3. Taichman RS, Cooper C, Keller ET et al (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62:1832–1837

    CAS  PubMed  Google Scholar 

  4. Scotton CJ, Wilson JL, Milliken D et al (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61:4961–4965

    CAS  PubMed  Google Scholar 

  5. Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56

    Article  CAS  PubMed  Google Scholar 

  6. Koshiba T, Hosotani R, Miyamoto Y et al (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: A possible role for tumor progression. Clin Cancer Res 6:3530–3535

    CAS  PubMed  Google Scholar 

  7. Ben-Baruch A (2003) Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5:31–36

    Article  CAS  PubMed  Google Scholar 

  8. Kato M, Kitayama J, Kazama S, Nagawa H (2003) Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5:R144–R150

    Article  CAS  PubMed  Google Scholar 

  9. Kollmar O, Rupertus K, Scheuer C et al (2007) Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 9:862–870

    Article  CAS  PubMed  Google Scholar 

  10. Guleng B, Tateishi K, Ohta M et al (2005) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65:5864–5871

    Article  CAS  PubMed  Google Scholar 

  11. Zeelenberg IS, Ruuls-Van Stalle L, Roos E (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:3833–3839

    CAS  PubMed  Google Scholar 

  12. Salvucci O, Bouchard A, Baccarelli A et al (2006) The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 97:275–283

    Article  CAS  PubMed  Google Scholar 

  13. Lin SY, Makino K, Xia W et al (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3:802–808

    Article  CAS  PubMed  Google Scholar 

  14. Ueda Y, Neel NF, Schutyser E et al (2006) Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Res 66:5665–5675

    Article  CAS  PubMed  Google Scholar 

  15. Diaz GA (2005) CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 203:235–243

    Article  CAS  PubMed  Google Scholar 

  16. Wittekind C, Greene FL, Henson DE et al (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley, New York, pp 97–123

    Google Scholar 

  17. Shim H, Lau SK, Devi S et al (2006) Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. Biochem Biophys Res Commun 346:252–258

    Article  CAS  PubMed  Google Scholar 

  18. Lo HW, Xia W, Wei Y et al (2005) Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 65:338–348

    CAS  PubMed  Google Scholar 

  19. Geminder H, Sagi-Assif O, Goldberg L et al (2001) A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone metastasis in neuroblastoma. J Immunol 167:4747–4757

    CAS  PubMed  Google Scholar 

  20. Mohle R, Failenschmid C, Bautz F, Kanz L (1999) Overexpression of chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to SDF-1. Leukemia 13:1954–1959

    Article  CAS  PubMed  Google Scholar 

  21. Tarasova NI, Stauber RH, Michejda CJ (1998) Spontaneous and ligand induced trafficking of CXC-chemokine receptor 4. J Biol Chem 273:15883–15886

    Article  CAS  PubMed  Google Scholar 

  22. Wang N, Wu QL, Fang Y et al (2005) Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. J Transl Med 3:26–30

    Article  PubMed  Google Scholar 

  23. Spano JP, Andre F, Morat L et al (2004) Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15:613–617

    Article  PubMed  Google Scholar 

  24. Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P (2002) Barnard GF.Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation. Jpn J Cancer Res 93:789–797

    CAS  PubMed  Google Scholar 

  25. Yoshitake N, Fukui YH, Sekikawa A, Fujii S, Tomita S, Ichikawa K, Imura J, Hiraishi H, Fujimori T (2008) Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98:1682–1689

    Article  CAS  PubMed  Google Scholar 

  26. Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper SC, Horuk R, Ali H, Snyderman R (1997) Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem 272:28726–28731

    Article  CAS  PubMed  Google Scholar 

  27. Kucia M, Reca R, Miekus K et al (2005) Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23:879–894

    Article  CAS  PubMed  Google Scholar 

  28. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS (2005) Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23:2744–2753

    Article  CAS  PubMed  Google Scholar 

  29. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  CAS  PubMed  Google Scholar 

  30. Chang SC, Lin PC, Yang SH et al (2009) SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol 16:2323–2330

    Article  PubMed  Google Scholar 

  31. Lapteva N, Yang AG, Sanders DE et al (2005) CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther 12:84–89

    Article  CAS  PubMed  Google Scholar 

  32. Smith MC, Luker KE, Garbow JR et al (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64:8604–8612

    Article  CAS  PubMed  Google Scholar 

  33. Rubin JB, Kung AL, Klein RS et al (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100:13513–13518

    Article  CAS  PubMed  Google Scholar 

  34. Dommange F, Cartron G, Espanel C et al (2006) CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB J 20:1913–1915

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by the grants from Taipei-Veterans General Hospital (V99C1-011, V99A-015, V98C1-093).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shih-Ching Chang.

Electronic supplementary materials

Supplementary Table

Staged 5-year survival rate (95% confidence interval) of 388 CRC patients in relation to cytoplasmic or nuclear CXCR4 status (DOC 24 kb)

Supplementary Fig. 1

(GIF 131 kb)

High resolution image file. (TIFF 614 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SC., Lin, JK., Wang, HS. et al. Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis 25, 1185–1191 (2010). https://doi.org/10.1007/s00384-010-0999-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-010-0999-1

Keywords

Navigation